secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEAYA Biosciences, Inc. (IDYA)
CIK:        0001676725
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0000950170-23-026512
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

IDEAYA signs 10-year lease for new 44,000 sq ft South San Francisco HQ
----------------------------------------------------------------------

- Leased ~44,000 sq ft of lab/office space at 5000 Shoreline Ct, South San Francisco, adjacent to current HQ.
- Total base rent over initial 10-year term net of abatement: $36.8 million.
- Expected occupancy Q2/Q3 2024; two 5-year renewal options at market rate.
- Company anticipates no material tenant improvement costs; facility supports R&D expansion.
- Existing cash expected to fund operations into 2027, inclusive of lease expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676725/000095017023026512/0000950170-23-026512-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676725/000095017023026512/idya-20230601.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-026512

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer